COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eder, Michael, Strassl, Robert, Kläger, Johannes, Aigner, Christof, Thalhammer, Florian, Kikić, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722244/
https://www.ncbi.nlm.nih.gov/pubmed/33289854
http://dx.doi.org/10.1007/s00508-020-01776-w
Descripción
Sumario:In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.

Ejemplares similares